Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Croghan

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Health Affairs (Project Hope)|March 23, 2001
The controversy of increased spending for antidepressantsT W Croghan
Medical Care|April 27, 1999
Use of claims data for research on treatment and outcomes of depression careC A Melfi, T W Croghan
Medical Care Research and Review : MCRR|December 6, 2000
Determinants of antidepressant treatment compliance: implications for policyM Tai-Seale, T W Croghan, R Obenchain
Journal of Health Care for the Poor and Underserved|May 4, 1999
Access to treatment for depression in a Medicaid populationC A Melfi, T W Croghan, M P Hanna
Archives of Internal Medicine|July 25, 2000
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherenceM R DiMatteo, H S Lepper, T W Croghan
Health Affairs (Project Hope)|September 25, 1999
Does the Americans with Disabilities Act accommodate depressed workers?T W Croghan, T J Kniesner, R H Powers
Health Affairs (Project Hope)|August 6, 1998
What does treatment of depression really cost?T W Croghan, R L Obenchain, W E Crown
Clinical Immunology and Immunopathology|November 1, 1985
Relationship of anti-beta 2-microglobulin antibodies to T11 and T-cell activation in systemic lupus erythematosusT W Croghan, S Minota, A Yamada, et al.
Administration and Policy in Mental Health|July 27, 2000
Effect of antidepressant choice on the incidence and economic intensity of hospitalization among depressed individualsT W Croghan, T J Kniesner, C A Melfi, et al.
Medical Care|April 27, 1999
Effect of mental health specialty care on antidepressant length of therapyT W Croghan, C A Melfi, D G Dobrez, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Health Affairs (Project Hope)|March 23, 2001
The controversy of increased spending for antidepressantsT W Croghan
Medical Care|April 27, 1999
Use of claims data for research on treatment and outcomes of depression careC A Melfi, T W Croghan
Medical Care Research and Review : MCRR|December 6, 2000
Determinants of antidepressant treatment compliance: implications for policyM Tai-Seale, T W Croghan, R Obenchain
Journal of Health Care for the Poor and Underserved|May 4, 1999
Access to treatment for depression in a Medicaid populationC A Melfi, T W Croghan, M P Hanna
Archives of Internal Medicine|July 25, 2000
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherenceM R DiMatteo, H S Lepper, T W Croghan
Health Affairs (Project Hope)|September 25, 1999
Does the Americans with Disabilities Act accommodate depressed workers?T W Croghan, T J Kniesner, R H Powers
Health Affairs (Project Hope)|August 6, 1998
What does treatment of depression really cost?T W Croghan, R L Obenchain, W E Crown
Clinical Immunology and Immunopathology|November 1, 1985
Relationship of anti-beta 2-microglobulin antibodies to T11 and T-cell activation in systemic lupus erythematosusT W Croghan, S Minota, A Yamada, et al.
Administration and Policy in Mental Health|July 27, 2000
Effect of antidepressant choice on the incidence and economic intensity of hospitalization among depressed individualsT W Croghan, T J Kniesner, C A Melfi, et al.
Medical Care|April 27, 1999
Effect of mental health specialty care on antidepressant length of therapyT W Croghan, C A Melfi, D G Dobrez, et al.
Pageof 3